Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection

FASEB Journal

Volumn 12, Issue 1, 1998, Pages 79-90

  Holme, Pål André ^a   Müller, Fredrik ^a   Solum, Nils Olav ^a   Brosstad, Frank ^a   FrØland, Stig S ^a   Aukrust, Pal ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antiretroviral therapy; HIV; P selection; Platelets; RANTES

Indexed keywords

AMINOPHOSPHOLIPID; INDINAVIR; PADGEM PROTEIN; RANTES;

ARTICLE; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INFLAMMATION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 2642649518     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.12.1.79     Document Type: Article

References (52)

1. Bierling, P., Bettaieb, A., and Oksenhendler, E. (1995) Human immunodeficiency virus-related immune thrombocytopenia. Semin. Thrombosis Hemostasis 21, 68-75
2. Weksler, B. B. (1992) Platelets. In Inflammation: Basic Principles and Clinical Correlates (Gallin, J. I., Goldstein, I. M., and Snyderman, R., eds) pp. 727-746, Raven Press, New York
3. Page, C. P. (1989) Platelets as inflammatory cells. Immunopharmacology 17, 51-59
4. Zalavary, S., Grenegård, M., Stendahl, O., and Bengtsson, T. (1996) Platelets enhance Fey receptor-mediated phagocytosis and respiratory burst in neutrophils: the role of purinergic modulation and actin polymerization. J. Leukoc. Biol. 60, 58-68
5. Chignard, M., and Renesto, P. (1994) Proteinases and cytokines in neutrophil and platelet interactions in vitro. Possible relevance to the adult respiratory distress syndrome. Ann. N. Y. Acad. Sci. 725, 309-322
6. Weyrich, A. S., Elstad, M. R., McEver, R. P., McIntyre, T. M., Moore, K. L., Morrissey, J. H., Prescott, S. M., and Zimmerman, G. A. (1996) Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 97, 1525-1534
7. Van, Z., Zhang, J., Holt, J. C., Stewart, G. J., Niewiarowski, S., and Poncz, M. (1994) Structural requirements of platelet chemokines for neutrophil activation. Blood 84, 2329-2339
8. Nagata, K., Tsuji, T., Todoroki, N., Katagiri, Y., Tanoue, K., Yamazaki, H., Hanai, N., and Irimura, T. (1993) Activated platelets induce Superoxide anion release by monocyte and neutrophils through P-selectin (CD62). J. Immunol. 151, 3267-3273
9. Hawrylowicz, C. M., Santoro, S. A., Platt, F. M., and Unanue, E. R. (1989) Activated platelets express IL-1 activity. J. Immunol. 143, 4015-4018
10. Merino, J., Casado, J. A., Cid, J., Sánchez-Ibarrola, A., and Subirá, M. L. (1992) The measurement of transforming growth factor type β (TGFβ) levels produced by peripheral blood mononuclear cells requires the efficient elimination of contaminating platelets. J. Immunol. Methods 153, 151-159
11. Kameyoshi, Y., Dörschner, A., Mallet, A. I., Christophers, E., and Schröder, J.-M. (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176, 587-592
12. Klinger, M. H. F., Wilhelm, D., Bubel, S., Sticherling, M., Schröder, J.-M., and Kühnel, W. (1995) Immunocytochemical localization of the chemokines RANTES and MIP-1α within human platelets and their release during storage. Int. Arch. Allergy Immunol. 107, 541-547
13. Su, S.-B., Mukaida, N., and Matsushima, K. (1996) Rapid secretion of intracellularly pre-stored interleukin-8 from rabbit platelets upon activation. J. Leukoc. Biol. 59, 420-426
14. Power, C. A., Furness, R. B., Brawand, C., and Wells, T. N. C. (1994) Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets. Gene 151, 333-334
15. Oryo, M., Sakamoto, H., Ogawa, Y., Tanaka, S., and Sakamoto, N. (1996) Effects of released products from platelets on neutrophilic adhesion to endothelial cells and nylon fibers. J. Leukoc. Biol. 60, 77-80
16. Centers for Disease Control and Prevention (1992) 1993 revised classification for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb. Mortal. Wkly. Rep. 41, 1-19
17. Holme, P. A., Solum, N. O., Brosstad, F., Egberg, N., and Lindahl, T. L. (1995) Stimulated Glanzmann's thrombasthenia patients produce microvesicles. Thromb. Haemost. 74, 1533-1540
18. Aukrust, P., Liabakk, N.-B., Müller, F., Lien, E., Espevik, T., and Frøland, S. S. (1994) Serum levels of tumor necrosis factor (TNF) α and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlation to clinical, immunologic and virologic parameters. J. Infect. Dis. 169, 420-424
19. Shattil, S. J., Hoxie, J. A., Cunningham, M., and Brass, L. F. (1985) Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J. Biol. Chem. 260, 11107-11114
20. Tait, J. F., Gibson, D., and Fujikawa, K. (1989) Phospholipid binding properties of human placental anticoagulant protein-1, a member of the lipocortin family. J. Biol. Chem. 264, 7944-7949
21. a receptor. Biochemistry 29, 623-632
22. Holme, P. A., Solum, N. O., Brosstad, F., Røger, M., and Abdelnoor, M. (1994) Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using filtration technique and Western blotting. Thromb. Haemost. 72, 666-671
23. Jy, W., Horstman, L., Arce, M., and Ahn, Y. S. (1992) Clinical significance of platelet fragmentation associated with idiopathic/autoimmune thrombocytopenias. J. Lab. Clin. Med. 119, 334-345
24. Michelson, A. D., Ellis, P. A., Barnard, M. R., Matic, G. B., Viles, A. F., and Kestin, A. S. (1991) Down regulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosin diphosphate, or an in vivo wound. Blood 77, 770-779
25. Fauci, A. S. (1996) Host factors and the pathogenesis of HIV-induced disease. Nature (London) 384, 529-533
26. Stein, D. S., Fish, D. G., Bilello, J. A., Preston, S. L., Martineau, G. I., and Drusano, G. I. (1996) A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (Indinavir). AIDS 10, 485-492
27. Baggiolini, M., Dewald, B., and Moser, B. (1994) Interleukin 8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55, 97-197
28. Hedrick, J. A., and Zlotnik, A. (1996) Chemokines and lymphocyte biology. Curr. Opin. Immunol. 8, 343-347
29. + T cells. Science 270, 1811-1815
30. Schall, T. J., Jongstra, J., Bradeley, B. J., Dyer, J., Jorgensen, J., Clayberg, C., Davis, M., and Krensky, A. M. (1988) A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141, 1018-1025
31. Abrams, C. S., Ellison, N., Budzynski, A. Z., and Shattil, S. J. (1990) Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 75, 128-138
32. Tschoepe, D., Roesen, P., Esser, J., Schwippert, B., Neuwenhuis, H. K., Kehrel, B., and Gries, F. A. (1991) Large platelets circulate in an activated state in diabetes mellitus. Semin. Thromb. Hemostasis 17, 433-438
33. Janes, S. L., Kyle, P. M., Redman, C., and Goodall, A. H. (1995) Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb. Haemost. 74, 1059-1063
34. Lundahl, T. H., Lindahl, T. L., Fagerberg, I. H., Egberg, N., Bunescu, A., and Larsson, A. (1996) Activated platelets and impaired platelet function in intensive care patients analysed by flow cytometry. Blood Coagul. Fibrinolysis 7, 218
35. Holme, P. A., Øvrim, U., Hamers, M. J. A. G., Solum, N. O., Brosstad, F., Barstad, R. M., and Sakariassen, K. (1997) Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with severe stenosis. Arterioscler. Thromb. Vasc. Biol. 17, 646-653
36. Taub, R., Gould, R. J., Garsky, V. M., Ciccarone, T. M., Hoxie, J., Friedman, P. A., and Shattil, S. J. (1989) A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J. Biol. Chem. 264, 259-265
37. Murakami, T., Komiyama, Y., Masuda, M., Kido, H., Nomura, S., Fukuhara, S., Karaqkawa, M., Iwasaka, T., and Takahashi, H. (1996) Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary heart disease. Eur. J. Clin. Invest. 26, 996-1003
38. +) hematopoietic progenitors in human immunodeficiency virus-I seropositivethrombocytopenic individuals. Blood 79, 2680-2689
39. Zucker-Franklin, D., Seremetis, S., and Zheng, Z. Y. (1990) Internalization of human immunodeficiency virus type 1 and other retroviruses by megakaryocytes and platelets. Blood 75, 120-123
40. Elbim, C., Prevot, M. H., Bouscarat, F., Franzini, E., Chollet-Martin, S., Hakim, J., and Gougerot-Pocidalo, M. A. (1994) Polymorphnuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming. Blood 84, 2759-2766
41. Todoroki, N., Watanabe,Y., Akaike, T., Ktagiri, Y., Tanoue, H., Yamazaki, T., Tsuji, T., Toyoshima, S., and Osawa, T. (1991) Enhancement by IL-1β and INF-γ of platelet activation: adhesion to leukocytes via GMP-140/PADGEM protein (CD62). Biochem. Biophys. Res. Commun. 179, 756-761
42. Toulon, P., Lamine, M., Ledjev, I., Guez, T., Holleman, M. E., Sereni, D., and Sicard, D. (1993) Heparin cofactor II deficiency in patients infected with human immunodeficiency virus. Thomb. Haemost. 70, 730-735
43. Bissuel, F., Berruyer, M., Causse, X., Dechavanne, M., and Trepo, C. (1992) Acquired protein S deficiency: correlation with disease in HIV-1-infected patients. J. Acquired Immune Defic. Syndr. 5, 484-489
44. Weyrich, A. S., McIntyre, T. M., McEver, R. P., Prescott, S. M., and Zimmerman, G. A. (1995) Monocyte tethering by P-selectin regulated monocyte chemotactic protein-1 and tumor necrosis factor α secretion. J. Clin. Invest. 95, 2297-2303
45. Baeuerle, P.A., and Henkel, T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-174
46. + lymphocytes and regulates their production of proinflammatory cytokines. Eur. J. Immunol. 22, 1789-1793
47. Clerici, M., Balotta, C., Trabattoni, D., Papagno, L., Ruzzante, S., Rusconi, S., Fusi, M. L., Colombo, M. C., and Galli, M., et al. (1996) Chemokine production in HIV-seropositive long-term asymptomatic individuals. AIDS 10, 1432-1433
48. + T cell-mediated suppression of HIV replication: β-chemokine-dependent and -independent effects. AIDS Res. Hum. Retrovir. 13, 63-69
49. Strieter, R. M., Standiford, T. J., Huffnagle, G. B., Colletti, L. M., Lukacs, N. W., and Kunkel, S. L. (1996) "The good, the bad and the ugly": the role of chemokines in models of human disease. J. Immunol. 356, 3583-3586
50. FAX and ZAP-70 in human T cells. J. Exp. Med. 184, 873-882
51. Bacon, K. B., Premack, B. A., Gardner, P., and Schall, T. J. (1995) Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269, 1727-1730
52. Gris, J.-C., Toulon, P., Brun, S., Maugard, C., Sarlat, C., Schved, J.-F., and Berlan, J. (1996) The relationship between plasma mi- croparticles, protein S and anticardiolipin antibodies in patients with human immunodeficiency virus infection. Thromb. Haemost. 76, 38-45